Last updated: Aug 1, 2003

Drug Reimportation Bill Verifies Industry's Financial Influence

Jul 24, 2003, 21:57

A bill that allows drug reimportation as a means to provide low-cost prescriptions to Americans was passed in the House just last week by a vote of 243-186. The bill permits drugs that are sold overseas to be reimported into the US and sold at a lower cost. The unfortunate ending to this vote confirms that campaign contributions from the pharmaceutical industry play a big role in influencing the decisions of our lawmakers.